{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:18:59Z","timestamp":1762917539726},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":480,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Magn. Reson. Imaging"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1002\/jmri.24650","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T06:15:25Z","timestamp":1399616125000},"page":"1259-1267","source":"Crossref","is-referenced-by-count":17,"title":["Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents"],"prefix":"10.1002","volume":"41","author":[{"given":"Emmanuil","family":"Smorodinsky","sequence":"first","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"},{"name":"Department of Imaging; Cedars Sinai Medical Center; Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Ansdell","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeke W.","family":"Foster","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer M.","family":"Mazhar","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Cruite","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"},{"name":"Department of Radiology; University of Washington Medical Center; Seattle Washington USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Wolfson","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian B.","family":"Sugay","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Iussich","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Shiehmorteza","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kono","sequence":"additional","affiliation":[{"name":"Liver Center; Department of Gastroenterology and Digestive Diseases; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kuo","sequence":"additional","affiliation":[{"name":"Liver Center; Department of Gastroenterology and Digestive Diseases; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude B.","family":"Sirlin","sequence":"additional","affiliation":[{"name":"Liver Imaging Group; Department of Radiology; University of California; San Diego San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"10.1002\/jmri.24650-BIB0001|jmri24650-cit-0001","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/jmri.24650-BIB0002|jmri24650-cit-0002","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1002\/jmri.24650-BIB0003|jmri24650-cit-0003","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/jmri.24650-BIB0004|jmri24650-cit-0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jmri.24650-BIB0005|jmri24650-cit-0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","article-title":"Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy","volume":"41","author":"White","year":"2006","journal-title":"Invest Radiol"},{"key":"10.1002\/jmri.24650-BIB0006|jmri24650-cit-0006","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.21966","article-title":"Primer on gadolinium chemistry","volume":"30","author":"Sherry","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1002\/jmri.24650-BIB0007|jmri24650-cit-0007","unstructured":"http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/DrugSafetyandRiskManagementAdvisoryCommittee\/UCM190850.pdf"},{"key":"10.1002\/jmri.24650-BIB0008|jmri24650-cit-0008","unstructured":"www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm053112.htm"},{"key":"10.1002\/jmri.24650-BIB0009|jmri24650-cit-0009","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm142884.htm"},{"key":"10.1002\/jmri.24650-BIB0010|jmri24650-cit-0010","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jmri.21983","article-title":"Nephrogenic systemic fibrosis in liver disease: a systematic review","volume":"30","author":"Mazhar","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1002\/jmri.24650-BIB0011|jmri24650-cit-0011","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1002\/jmri.24650-BIB0012|jmri24650-cit-0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","article-title":"Nephrogenic systemic fibrosis: risk factors and incidence estimation","volume":"243","author":"Sadowski","year":"2007","journal-title":"Radiology"},{"key":"10.1002\/jmri.24650-BIB0013|jmri24650-cit-0013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiol.2423061640","article-title":"Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis","volume":"242","author":"Kuo","year":"2007","journal-title":"Radiology"},{"key":"10.1002\/jmri.24650-BIB0014|jmri24650-cit-0014","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2502080498","article-title":"Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases","volume":"250","author":"Perez-Rodriguez","year":"2009","journal-title":"Radiology"},{"key":"10.1002\/jmri.24650-BIB0015|jmri24650-cit-0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jmri.21973","article-title":"Risk factors for NSF: a literature review","volume":"30","author":"Prince","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1002\/jmri.24650-BIB0016|jmri24650-cit-0016","unstructured":"http:\/\/www.kidney.org\/PROFESSIONALS\/kdoqi\/guidelines_ckd\/toc.htm"},{"key":"10.1002\/jmri.24650-BIB0017|jmri24650-cit-0017","unstructured":""},{"key":"10.1002\/jmri.24650-BIB0018|jmri24650-cit-0018","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"American Statistician"},{"key":"10.1002\/jmri.24650-BIB0019|jmri24650-cit-0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/lt.20068","article-title":"Nephrogenic fibrosing dermopathy: a rare entity in patients awaiting liver transplantation","volume":"10","author":"Chiu","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1002\/jmri.24650-BIB0020|jmri24650-cit-0020","unstructured":"Saddleton E"},{"key":"10.1002\/jmri.24650-BIB0021|jmri24650-cit-0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0019-5154.77556","article-title":"Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases","volume":"56","author":"Zou","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1002\/jmri.24650-BIB0022|jmri24650-cit-0022","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2214\/AJR.10.5976","article-title":"Risk of nephrogenic systemic fibrosis in liver transplantation patients","volume":"197","author":"Chow","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1002\/jmri.24650-BIB0023|jmri24650-cit-0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/jmri.24650-BIB0024|jmri24650-cit-0024","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1002\/jmri.24650-BIB0025|jmri24650-cit-0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archdermatol.2009.232","article-title":"Large sample of nephrogenic systemic fibrosis cases from a single institution","volume":"145","author":"Lee","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1002\/jmri.24650-BIB0026|jmri24650-cit-0026","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J Hepatol"},{"key":"10.1002\/jmri.24650-BIB0027|jmri24650-cit-0027","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9343(87)90156-2","article-title":"Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study","volume":"82","author":"Papadakis","year":"1987","journal-title":"Am J Med"},{"key":"10.1002\/jmri.24650-BIB0028|jmri24650-cit-0028","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MNH.0b013e3283309660","article-title":"Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm","volume":"18","author":"Perazella","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1002\/jmri.24650-BIB0029|jmri24650-cit-0029","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1600-0560.2009.01283.x","article-title":"Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis","volume":"36","author":"Thakral","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1002\/jmri.24650-BIB0030|jmri24650-cit-0030","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jmri.21135","article-title":"Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis","volume":"26","author":"Ersoy","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1002\/jmri.24650-BIB0031|jmri24650-cit-0031","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1002\/jmri.24650-BIB0032|jmri24650-cit-0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004424-200001000-00004","article-title":"Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure","volume":"35","author":"Tombach","year":"2000","journal-title":"Invest Radiol"},{"key":"10.1002\/jmri.24650-BIB0033|jmri24650-cit-0033","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4329\/wjr.v2.i11.427","article-title":"Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data","volume":"2","author":"Morcos","year":"2010","journal-title":"World J Radiol"},{"key":"10.1002\/jmri.24650-BIB0034|jmri24650-cit-0034","doi-asserted-by":"crossref","first-page":"c24","DOI":"10.1159\/000151228","article-title":"Nephrogenic systemic fibrosis: more questions and some answers","volume":"110","author":"Morcos","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1002\/jmri.24650-BIB0035|jmri24650-cit-0035","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/path.2311","article-title":"Gadodiamide contrast agent \u2018activates\u2019 fibroblasts: a possible cause of nephrogenic systemic fibrosis","volume":"214","author":"Edward","year":"2008","journal-title":"J Pathol"},{"key":"10.1002\/jmri.24650-BIB0036|jmri24650-cit-0036","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.10091131","article-title":"Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation","volume":"256","author":"Edward","year":"2010","journal-title":"Radiology"},{"key":"10.1002\/jmri.24650-BIB0037|jmri24650-cit-0037","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1472-8206.2006.00447.x","article-title":"Clinical and biological consequences of 1 transmetallation induced by contrast agents for magnetic resonance imaging: a review","volume":"20","author":"Idee","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1002\/jmri.24650-BIB0038|jmri24650-cit-0038","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejrad.2008.01.028","article-title":"Nephrogenic systemic fibrosis-implications for nephrologists","volume":"66","author":"Saab","year":"2008","journal-title":"Eur J Radiol"}],"container-title":["Journal of Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmri.24650","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jmri.24650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T16:11:31Z","timestamp":1625328691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmri.24650"}},"subtitle":["NSF in Chronic Liver Disease"],"short-title":[],"issued":{"date-parts":[[2014,5,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/jmri.24650","relation":{},"ISSN":["1053-1807"],"issn-type":[{"value":"1053-1807","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,9]]}}}